AbbVie: Retinal Vein Occlusion trials

The registry lists 16 Retinal Vein Occlusion studies with AbbVie as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 1 1Phase 2 2Phase 3 2Phase 4 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®CompletedNCT02181530Results posted
• Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in KoreaCompletedNCT01976650Results posted
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular EdemaCompletedNCT01918371Results posted
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein OcclusionCompletedNCT01903720Phase 4Results posted
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein OcclusionCompletedNCT01618266Results posted
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01571557Results posted
• Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)CompletedNCT01568021Results posted
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein OcclusionCompletedNCT01566526Results posted
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4Results posted
• Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)CompletedNCT01411696Results posted
• Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)CompletedNCT01027650Phase 1/2Results posted
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168324Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168298Phase 3Results posted
• Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in ChinaCompletedNCT03908307Phase 4
• A Long-Term Safety Study of OZURDEX® in Clinical PracticeCompletedNCT01539577
• Research Study in Patients With Persistent Macular EdemaCompletedNCT00035906Phase 2